Gene Expression Profile of Breast Cancer Samples After Vitamin D Supplementation

Clinical Trial ID NCT00926315

Rank	Title	Journal	Year	PubWeight™‹?›
1	Gene expression profile associated with response to doxorubicin-based therapy in breast cancer.	Clin Cancer Res	2005	1.46
2	25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of 1alpha-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer.	J Steroid Biochem Mol Biol	2006	0.98
3	Antiproliferative effects of 1,25-dihydroxyvitamin D3 on breast cells: a mini review.	Braz J Med Biol Res	2002	0.85
4	Ras activation is associated with vitamin D receptor mRNA instability in HC11 mammary cells.	J Steroid Biochem Mol Biol	2004	0.84
5	Expression of vitamin D receptor mRNA in the hippocampal formation of rats submitted to a model of temporal lobe epilepsy induced by pilocarpine.	Brain Res Bull	2008	0.78
6	Molecular targets of 1,25(OH)2D3 in HC11 normal mouse mammary cell line.	J Steroid Biochem Mol Biol	2003	0.77
7	Expression of vitamin D receptor (VDR) in HL-60 cells is differentially regulated during the process of differentiation induced by phorbol ester, retinoic acid or interferon-gamma.	J Steroid Biochem Mol Biol	1998	0.76